Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEIS2
|
ENSG00000134138.15 | Meis homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_37387462_37387763 | MEIS2 | 390 | 0.871649 | -0.87 | 2.0e-03 | Click! |
chr15_37402971_37403122 | MEIS2 | 9542 | 0.226269 | -0.85 | 4.0e-03 | Click! |
chr15_37402742_37402893 | MEIS2 | 9313 | 0.226705 | -0.84 | 4.4e-03 | Click! |
chr15_37394546_37394764 | MEIS2 | 1151 | 0.518203 | -0.77 | 1.6e-02 | Click! |
chr15_37390143_37390314 | MEIS2 | 275 | 0.883031 | -0.72 | 2.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrY_117140_117541 | 2.20 |
NA |
NA |
> 106 |
NA |
chr17_78845626_78846398 | 1.86 |
RPTOR |
regulatory associated protein of MTOR, complex 1 |
50512 |
0.1 |
chr17_76875045_76875748 | 1.31 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
5164 |
0.16 |
chr12_121678757_121679425 | 1.29 |
CAMKK2 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
19254 |
0.17 |
chr10_76672520_76672974 | 1.09 |
KAT6B |
K(lysine) acetyltransferase 6B |
74289 |
0.1 |
chr20_8380540_8381084 | 0.99 |
PLCB1-IT1 |
PLCB1 intronic transcript 1 (non-protein coding) |
151440 |
0.04 |
chr11_68319868_68320209 | 0.91 |
PPP6R3 |
protein phosphatase 6, regulatory subunit 3 |
6072 |
0.21 |
chr10_114139672_114139929 | 0.91 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
3843 |
0.23 |
chrX_167199_167448 | 0.90 |
PLCXD1 |
phosphatidylinositol-specific phospholipase C, X domain containing 1 |
25666 |
0.23 |
chr22_40642780_40643209 | 0.90 |
TNRC6B |
trinucleotide repeat containing 6B |
18013 |
0.23 |
chr8_22499257_22499720 | 0.89 |
BIN3 |
bridging integrator 3 |
2829 |
0.16 |
chr6_159125474_159126340 | 0.88 |
SYTL3 |
synaptotagmin-like 3 |
41712 |
0.13 |
chr16_29129607_29129944 | 0.86 |
CTB-134H23.3 |
|
11009 |
0.16 |
chr8_125575470_125576116 | 0.85 |
MTSS1 |
metastasis suppressor 1 |
2175 |
0.26 |
chr6_170404847_170405519 | 0.84 |
RP11-302L19.1 |
|
72558 |
0.11 |
chr15_50392799_50393114 | 0.84 |
ATP8B4 |
ATPase, class I, type 8B, member 4 |
13745 |
0.23 |
chr3_196368477_196368981 | 0.83 |
PIGX |
phosphatidylinositol glycan anchor biosynthesis, class X |
2083 |
0.21 |
chr8_21766211_21767399 | 0.83 |
DOK2 |
docking protein 2, 56kDa |
4369 |
0.22 |
chr10_51503867_51504211 | 0.83 |
AGAP7 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 7 |
17712 |
0.18 |
chr18_2883602_2883982 | 0.81 |
EMILIN2 |
elastin microfibril interfacer 2 |
36764 |
0.11 |
chr17_72008045_72008710 | 0.81 |
RPL38 |
ribosomal protein L38 |
191344 |
0.02 |
chr3_16551168_16551938 | 0.80 |
RFTN1 |
raftlin, lipid raft linker 1 |
2858 |
0.36 |
chr11_587585_588264 | 0.80 |
PHRF1 |
PHD and ring finger domains 1 |
11403 |
0.07 |
chr12_68841133_68841474 | 0.80 |
MDM1 |
Mdm1 nuclear protein homolog (mouse) |
115142 |
0.06 |
chr3_141218689_141219075 | 0.80 |
RASA2 |
RAS p21 protein activator 2 |
12991 |
0.21 |
chr12_65043801_65044168 | 0.80 |
RP11-338E21.3 |
|
4815 |
0.15 |
chr20_39510251_39510483 | 0.79 |
ENSG00000238908 |
. |
27498 |
0.24 |
chr11_4006180_4006517 | 0.78 |
STIM1 |
stromal interaction molecule 1 |
37775 |
0.14 |
chr11_129988351_129988943 | 0.78 |
ST14 |
suppression of tumorigenicity 14 (colon carcinoma) |
40810 |
0.15 |
chr2_241504090_241504573 | 0.78 |
RNPEPL1 |
arginyl aminopeptidase (aminopeptidase B)-like 1 |
890 |
0.44 |
chr9_37486177_37486967 | 0.78 |
POLR1E |
polymerase (RNA) I polypeptide E, 53kDa |
422 |
0.8 |
chr2_136814753_136815076 | 0.78 |
AC093391.2 |
|
44879 |
0.15 |
chr14_98689187_98689819 | 0.77 |
ENSG00000222066 |
. |
108584 |
0.07 |
chrX_1689699_1690290 | 0.77 |
AKAP17A |
A kinase (PRKA) anchor protein 17A |
20492 |
0.18 |
chr17_19273582_19274475 | 0.77 |
MAPK7 |
mitogen-activated protein kinase 7 |
7006 |
0.11 |
chr5_169232621_169233022 | 0.77 |
CTB-37A13.1 |
|
26452 |
0.22 |
chr21_36800534_36801386 | 0.76 |
ENSG00000211590 |
. |
292053 |
0.01 |
chr11_3918269_3918516 | 0.76 |
STIM1 |
stromal interaction molecule 1 |
6301 |
0.14 |
chr9_4596503_4596823 | 0.75 |
SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
24328 |
0.19 |
chr5_96232467_96233018 | 0.75 |
ERAP2 |
endoplasmic reticulum aminopeptidase 2 |
7821 |
0.17 |
chr14_91718270_91718619 | 0.73 |
GPR68 |
G protein-coupled receptor 68 |
1780 |
0.32 |
chr16_30470032_30470581 | 0.73 |
ENSG00000202476 |
. |
4888 |
0.07 |
chr6_37891842_37892090 | 0.73 |
ZFAND3 |
zinc finger, AN1-type domain 3 |
5769 |
0.23 |
chr9_129285864_129286127 | 0.73 |
ENSG00000221768 |
. |
7275 |
0.22 |
chr7_102069746_102070456 | 0.73 |
ORAI2 |
ORAI calcium release-activated calcium modulator 2 |
3452 |
0.11 |
chr18_60880832_60881273 | 0.72 |
ENSG00000238988 |
. |
19154 |
0.21 |
chr9_112827201_112827453 | 0.72 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
16351 |
0.27 |
chr2_10521424_10521869 | 0.72 |
HPCAL1 |
hippocalcin-like 1 |
38501 |
0.14 |
chr11_68272006_68272464 | 0.71 |
ENSG00000222339 |
. |
884 |
0.48 |
chr1_156477763_156478531 | 0.71 |
MEF2D |
myocyte enhancer factor 2D |
7527 |
0.12 |
chr8_22562900_22563666 | 0.70 |
EGR3 |
early growth response 3 |
12468 |
0.13 |
chr17_74265724_74266071 | 0.70 |
UBALD2 |
UBA-like domain containing 2 |
4113 |
0.15 |
chr2_70331989_70332203 | 0.69 |
PCBP1-AS1 |
PCBP1 antisense RNA 1 |
16118 |
0.15 |
chr11_1145070_1145742 | 0.69 |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
6174 |
0.2 |
chr8_37132456_37132991 | 0.69 |
RP11-150O12.6 |
|
241816 |
0.02 |
chr14_100568508_100568904 | 0.69 |
EVL |
Enah/Vasp-like |
5422 |
0.14 |
chr7_139922545_139922896 | 0.68 |
ENSG00000199971 |
. |
13249 |
0.16 |
chr17_57442435_57442935 | 0.68 |
ENSG00000263857 |
. |
759 |
0.63 |
chr22_24830948_24831363 | 0.68 |
ADORA2A |
adenosine A2a receptor |
2347 |
0.28 |
chr3_66534161_66534516 | 0.68 |
LRIG1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
17018 |
0.29 |
chr19_14486268_14486999 | 0.67 |
CD97 |
CD97 molecule |
5335 |
0.16 |
chr6_10413127_10413925 | 0.66 |
TFAP2A |
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
414 |
0.77 |
chr2_242067669_242067932 | 0.66 |
PASK |
PAS domain containing serine/threonine kinase |
11210 |
0.14 |
chr10_12636480_12636937 | 0.66 |
ENSG00000263584 |
. |
15956 |
0.26 |
chr6_3026729_3027148 | 0.66 |
RP1-90J20.11 |
|
1913 |
0.25 |
chr9_77765507_77765901 | 0.66 |
ENSG00000200041 |
. |
30833 |
0.16 |
chr3_23935568_23935872 | 0.66 |
RPL15 |
ribosomal protein L15 |
22316 |
0.17 |
chr1_2174913_2175173 | 0.66 |
SKI |
v-ski avian sarcoma viral oncogene homolog |
14909 |
0.12 |
chr16_29611332_29612125 | 0.66 |
ENSG00000266758 |
. |
1142 |
0.43 |
chr2_145266955_145267602 | 0.65 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
7837 |
0.25 |
chr6_111880308_111880661 | 0.65 |
TRAF3IP2-AS1 |
TRAF3IP2 antisense RNA 1 |
5970 |
0.19 |
chr7_50354105_50354370 | 0.65 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
5919 |
0.31 |
chr2_3246663_3247121 | 0.65 |
TSSC1-IT1 |
TSSC1 intronic transcript 1 (non-protein coding) |
58344 |
0.14 |
chr9_92151633_92152777 | 0.65 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
39160 |
0.16 |
chrX_128888588_128889150 | 0.64 |
XPNPEP2 |
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
15871 |
0.19 |
chr4_4462962_4463617 | 0.64 |
STX18 |
syntaxin 18 |
392 |
0.87 |
chr3_197574613_197575155 | 0.64 |
LRCH3 |
leucine-rich repeats and calponin homology (CH) domain containing 3 |
12 |
0.98 |
chr3_71103539_71103766 | 0.64 |
FOXP1 |
forkhead box P1 |
10425 |
0.31 |
chr4_122111518_122111869 | 0.64 |
ENSG00000252183 |
. |
2365 |
0.34 |
chr10_104408471_104409659 | 0.64 |
TRIM8 |
tripartite motif containing 8 |
4421 |
0.2 |
chr11_48025895_48026348 | 0.64 |
AC103828.1 |
|
11286 |
0.2 |
chr17_73061461_73061965 | 0.64 |
KCTD2 |
potassium channel tetramerization domain containing 2 |
18373 |
0.07 |
chr5_169714509_169715053 | 0.63 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
10450 |
0.22 |
chr16_30483819_30483970 | 0.63 |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
85 |
0.88 |
chr12_15803315_15803614 | 0.63 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
11744 |
0.22 |
chr19_16483828_16484062 | 0.63 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
11181 |
0.14 |
chr19_16228666_16229162 | 0.63 |
RAB8A |
RAB8A, member RAS oncogene family |
6207 |
0.14 |
chr12_662501_663191 | 0.63 |
B4GALNT3 |
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
10547 |
0.16 |
chr9_116278367_116278657 | 0.63 |
RGS3 |
regulator of G-protein signaling 3 |
1038 |
0.59 |
chr2_37847075_37847226 | 0.63 |
AC006369.2 |
|
19871 |
0.22 |
chr3_99792803_99793269 | 0.62 |
FILIP1L |
filamin A interacting protein 1-like |
40321 |
0.15 |
chr13_100072786_100073153 | 0.62 |
ENSG00000266207 |
. |
32754 |
0.16 |
chr10_134235955_134236340 | 0.62 |
RP11-432J24.3 |
|
18841 |
0.16 |
chr16_57564544_57565110 | 0.62 |
CCDC102A |
coiled-coil domain containing 102A |
5684 |
0.15 |
chr18_60804974_60805454 | 0.62 |
RP11-299P2.1 |
|
13339 |
0.24 |
chr14_93122585_93123047 | 0.62 |
RIN3 |
Ras and Rab interactor 3 |
3970 |
0.31 |
chr13_99935557_99935841 | 0.62 |
GPR18 |
G protein-coupled receptor 18 |
21701 |
0.17 |
chr11_326229_326864 | 0.62 |
IFITM3 |
interferon induced transmembrane protein 3 |
991 |
0.28 |
chr17_36884755_36885077 | 0.62 |
AC006449.1 |
NS5ATP13TP1; Uncharacterized protein |
465 |
0.53 |
chr6_2901195_2901808 | 0.62 |
SERPINB9 |
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
2013 |
0.31 |
chr21_36345967_36346246 | 0.62 |
RUNX1 |
runt-related transcription factor 1 |
75356 |
0.12 |
chr16_1609129_1609769 | 0.62 |
LA16c-425C2.1 |
|
20860 |
0.08 |
chr2_42106310_42106729 | 0.62 |
ENSG00000223245 |
. |
8108 |
0.23 |
chr9_130789038_130789532 | 0.61 |
RP11-379C10.1 |
|
30356 |
0.08 |
chr22_30059316_30059467 | 0.61 |
RP1-76B20.12 |
|
56312 |
0.08 |
chr1_249116365_249116887 | 0.61 |
ENSG00000264500 |
. |
3950 |
0.17 |
chrX_13068365_13068668 | 0.61 |
FAM9C |
family with sequence similarity 9, member C |
5715 |
0.29 |
chr10_33208774_33208970 | 0.61 |
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
11441 |
0.29 |
chr10_6390281_6390901 | 0.61 |
DKFZP667F0711 |
|
1687 |
0.47 |
chr10_76660118_76660645 | 0.61 |
KAT6B |
K(lysine) acetyltransferase 6B |
61923 |
0.13 |
chr10_14639310_14639675 | 0.61 |
FAM107B |
family with sequence similarity 107, member B |
6896 |
0.24 |
chr2_27297539_27298497 | 0.61 |
OST4 |
oligosaccharyltransferase 4 homolog (S. cerevisiae) |
3377 |
0.09 |
chr16_84551314_84551501 | 0.61 |
TLDC1 |
TBC/LysM-associated domain containing 1 |
13043 |
0.17 |
chr1_209932210_209932881 | 0.60 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
702 |
0.6 |
chr1_168482288_168482558 | 0.60 |
XCL2 |
chemokine (C motif) ligand 2 |
30812 |
0.2 |
chr20_44712187_44712338 | 0.60 |
NCOA5 |
nuclear receptor coactivator 5 |
6329 |
0.17 |
chr13_99156494_99156904 | 0.60 |
STK24 |
serine/threonine kinase 24 |
14822 |
0.22 |
chr18_43268528_43268819 | 0.60 |
SLC14A2 |
solute carrier family 14 (urea transporter), member 2 |
22566 |
0.17 |
chr1_90117224_90117495 | 0.60 |
LRRC8C |
leucine rich repeat containing 8 family, member C |
18728 |
0.16 |
chrX_109941851_109942119 | 0.60 |
CHRDL1 |
chordin-like 1 |
97008 |
0.09 |
chr10_51499020_51499441 | 0.60 |
AGAP7 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 7 |
12903 |
0.2 |
chr9_21558528_21559235 | 0.60 |
MIR31HG |
MIR31 host gene (non-protein coding) |
787 |
0.64 |
chr1_95223071_95223415 | 0.60 |
ENSG00000263526 |
. |
11787 |
0.24 |
chr19_16555192_16555446 | 0.59 |
CTD-2013N17.4 |
|
3562 |
0.16 |
chr4_2299878_2300029 | 0.59 |
RP11-478C1.7 |
|
2642 |
0.2 |
chr19_18414911_18415207 | 0.59 |
LSM4 |
LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
12010 |
0.09 |
chr4_25845411_25845804 | 0.59 |
SEL1L3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
16646 |
0.24 |
chr7_44804340_44804491 | 0.59 |
ZMIZ2 |
zinc finger, MIZ-type containing 2 |
8611 |
0.16 |
chr8_128990046_128990302 | 0.59 |
ENSG00000221771 |
. |
17295 |
0.16 |
chr11_36112461_36112922 | 0.59 |
ENSG00000263389 |
. |
81043 |
0.09 |
chr16_68117516_68117708 | 0.59 |
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
1635 |
0.23 |
chr2_161329613_161329866 | 0.59 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
20290 |
0.24 |
chr17_57733680_57734015 | 0.59 |
CLTC |
clathrin, heavy chain (Hc) |
27420 |
0.15 |
chrX_13735290_13735441 | 0.59 |
TRAPPC2 |
trafficking protein particle complex 2 |
17310 |
0.16 |
chr1_226840930_226841348 | 0.59 |
ITPKB-IT1 |
ITPKB intronic transcript 1 (non-protein coding) |
6232 |
0.23 |
chr14_102323762_102323913 | 0.58 |
CTD-2017C7.1 |
|
17969 |
0.16 |
chr16_17441111_17441650 | 0.58 |
XYLT1 |
xylosyltransferase I |
123358 |
0.06 |
chr17_19993225_19993666 | 0.58 |
SPECC1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
3110 |
0.28 |
chr20_32119885_32120303 | 0.58 |
CBFA2T2 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 2 |
30046 |
0.15 |
chr15_40548529_40548680 | 0.58 |
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
3219 |
0.13 |
chr2_241560209_241560581 | 0.58 |
GPR35 |
G protein-coupled receptor 35 |
4267 |
0.16 |
chr19_16448880_16449487 | 0.58 |
KLF2 |
Kruppel-like factor 2 |
13532 |
0.14 |
chr8_116661022_116661259 | 0.58 |
TRPS1 |
trichorhinophalangeal syndrome I |
12765 |
0.31 |
chr22_24841252_24841667 | 0.58 |
ADORA2A |
adenosine A2a receptor |
12651 |
0.16 |
chr6_166900667_166901285 | 0.58 |
ENSG00000222958 |
. |
21945 |
0.16 |
chr6_154692239_154692666 | 0.58 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
14526 |
0.27 |
chr7_27004125_27004483 | 0.58 |
SKAP2 |
src kinase associated phosphoprotein 2 |
30554 |
0.16 |
chr10_6182182_6182929 | 0.57 |
PFKFB3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
4326 |
0.16 |
chr3_14274255_14274511 | 0.57 |
XPC |
xeroderma pigmentosum, complementation group C |
54100 |
0.12 |
chr20_8125317_8125709 | 0.57 |
PLCB1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
12211 |
0.27 |
chr2_65258054_65258356 | 0.56 |
AC007386.4 |
|
6426 |
0.18 |
chr1_202132763_202133787 | 0.56 |
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
2559 |
0.21 |
chr12_1755993_1756558 | 0.56 |
ENSG00000266043 |
. |
13271 |
0.18 |
chr6_91060753_91061282 | 0.56 |
ENSG00000266760 |
. |
38556 |
0.18 |
chr1_1207528_1208557 | 0.56 |
UBE2J2 |
ubiquitin-conjugating enzyme E2, J2 |
809 |
0.37 |
chr5_119633464_119633615 | 0.56 |
ENSG00000251975 |
. |
39809 |
0.22 |
chr3_196378797_196379044 | 0.56 |
PIGX |
phosphatidylinositol glycan anchor biosynthesis, class X |
12274 |
0.13 |
chr1_90013452_90013603 | 0.56 |
LRRC8B |
leucine rich repeat containing 8 family, member B |
20273 |
0.21 |
chr13_114831463_114832357 | 0.56 |
RASA3 |
RAS p21 protein activator 3 |
11528 |
0.24 |
chr2_176417653_176417879 | 0.56 |
ENSG00000221347 |
. |
222665 |
0.02 |
chr3_46033619_46034065 | 0.56 |
FYCO1 |
FYVE and coiled-coil domain containing 1 |
3465 |
0.23 |
chr2_68631463_68631827 | 0.56 |
AC015969.3 |
|
38929 |
0.13 |
chr8_144286298_144286449 | 0.56 |
GPIHBP1 |
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 |
8695 |
0.14 |
chr3_43237083_43237612 | 0.56 |
ENSG00000222331 |
. |
15016 |
0.22 |
chr9_123607989_123608514 | 0.55 |
PSMD5-AS1 |
PSMD5 antisense RNA 1 (head to head) |
324 |
0.87 |
chr17_2298935_2299087 | 0.55 |
MNT |
MAX network transcriptional repressor |
5387 |
0.12 |
chr1_56962140_56962350 | 0.55 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
82996 |
0.1 |
chr16_16119784_16120030 | 0.55 |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
16194 |
0.23 |
chr1_112015953_112016200 | 0.55 |
C1orf162 |
chromosome 1 open reading frame 162 |
338 |
0.78 |
chr5_126187384_126187849 | 0.55 |
MARCH3 |
membrane-associated ring finger (C3HC4) 3, E3 ubiquitin protein ligase |
66304 |
0.11 |
chr14_65556858_65557152 | 0.55 |
RP11-840I19.3 |
|
290 |
0.88 |
chr6_161647774_161647954 | 0.55 |
AGPAT4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
47187 |
0.2 |
chr20_24935566_24936123 | 0.55 |
CST7 |
cystatin F (leukocystatin) |
5978 |
0.21 |
chr1_155209419_155209779 | 0.55 |
GBA |
glucosidase, beta, acid |
1418 |
0.16 |
chr2_143902895_143903369 | 0.55 |
ARHGAP15 |
Rho GTPase activating protein 15 |
16249 |
0.23 |
chr1_54686195_54686878 | 0.55 |
MRPL37 |
mitochondrial ribosomal protein L37 |
10917 |
0.13 |
chr2_99105742_99105999 | 0.55 |
INPP4A |
inositol polyphosphate-4-phosphatase, type I, 107kDa |
30642 |
0.19 |
chr3_120162985_120163136 | 0.55 |
FSTL1 |
follistatin-like 1 |
6778 |
0.27 |
chr3_20165349_20165500 | 0.55 |
ENSG00000266745 |
. |
13633 |
0.19 |
chr7_114616275_114616426 | 0.55 |
MDFIC |
MyoD family inhibitor domain containing |
42426 |
0.21 |
chr17_1100600_1101315 | 0.55 |
ABR |
active BCR-related |
10341 |
0.19 |
chr3_150996404_150996654 | 0.54 |
P2RY14 |
purinergic receptor P2Y, G-protein coupled, 14 |
274 |
0.9 |
chr14_24837858_24838637 | 0.54 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
41 |
0.94 |
chr14_93053486_93054197 | 0.54 |
RIN3 |
Ras and Rab interactor 3 |
65005 |
0.13 |
chr4_37894193_37894870 | 0.54 |
TBC1D1 |
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
1811 |
0.44 |
chr3_18445696_18446011 | 0.54 |
RP11-158G18.1 |
|
5274 |
0.25 |
chr11_6676346_6676579 | 0.54 |
DCHS1 |
dachsous cadherin-related 1 |
623 |
0.54 |
chr5_98268754_98268997 | 0.54 |
ENSG00000200351 |
. |
3576 |
0.26 |
chr8_125207320_125207810 | 0.54 |
FER1L6-AS2 |
FER1L6 antisense RNA 2 |
23802 |
0.22 |
chr4_108951026_108951527 | 0.54 |
HADH |
hydroxyacyl-CoA dehydrogenase |
25485 |
0.19 |
chr1_112045793_112046152 | 0.54 |
ADORA3 |
adenosine A3 receptor |
138 |
0.93 |
chr3_31506056_31506507 | 0.54 |
STT3B |
STT3B, subunit of the oligosaccharyltransferase complex (catalytic) |
68001 |
0.12 |
chr9_127026264_127026636 | 0.54 |
RP11-121A14.3 |
|
1295 |
0.38 |
chr2_38861741_38862387 | 0.54 |
GALM |
galactose mutarotase (aldose 1-epimerase) |
30988 |
0.13 |
chr5_10537277_10538000 | 0.54 |
ANKRD33B |
ankyrin repeat domain 33B |
26942 |
0.15 |
chr8_121746886_121747646 | 0.54 |
RP11-713M15.1 |
|
26227 |
0.22 |
chr11_132555018_132555242 | 0.53 |
ENSG00000252703 |
. |
159427 |
0.04 |
chr10_134391633_134392261 | 0.53 |
INPP5A |
inositol polyphosphate-5-phosphatase, 40kDa |
29483 |
0.19 |
chr10_30783280_30783465 | 0.53 |
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8 |
55621 |
0.12 |
chr17_74140903_74141711 | 0.53 |
RNF157-AS1 |
RNF157 antisense RNA 1 |
3710 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 3.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.7 | 2.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.6 | 0.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.6 | 2.5 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.6 | 1.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.5 | 2.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.5 | 1.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 1.5 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.5 | 0.9 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.4 | 1.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 1.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.4 | 1.5 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 0.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 0.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 1.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 1.4 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.3 | 0.7 | GO:0052257 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) |
0.3 | 1.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.3 | 1.0 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 | 1.0 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 1.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 0.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 1.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 0.9 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 2.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 0.9 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 7.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.3 | 0.9 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.3 | 0.5 | GO:0033622 | integrin activation(GO:0033622) |
0.3 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.8 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.3 | 1.0 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.3 | 1.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 0.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.7 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 0.7 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.2 | 0.9 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.6 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 0.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 0.2 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.2 | 2.2 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 0.2 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.2 | 0.2 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.2 | 0.9 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.2 | 0.4 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.2 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.8 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.2 | 0.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.2 | GO:0032613 | interleukin-10 production(GO:0032613) |
0.2 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.2 | 1.6 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.2 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.8 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.2 | 0.8 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.9 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.2 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 1.5 | GO:0043368 | positive T cell selection(GO:0043368) |
0.2 | 0.6 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 1.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.9 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.2 | 1.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.9 | GO:0002858 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.2 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.2 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.2 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 0.3 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.5 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.2 | 0.3 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 0.3 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.2 | 2.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.8 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 0.6 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 0.6 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) negative regulation of glial cell proliferation(GO:0060253) |
0.2 | 2.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.5 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.5 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.5 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 1.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.1 | GO:0045079 | negative regulation of chemokine production(GO:0032682) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.6 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.1 | 0.1 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 1.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.1 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.5 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.4 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 0.5 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.6 | GO:0042119 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.5 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 1.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.7 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.9 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.1 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.1 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.1 | 2.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.6 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.3 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.1 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.2 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.5 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.2 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0032645 | granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) |
0.1 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.4 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.2 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.1 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.5 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.3 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.4 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.2 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 1.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.3 | GO:0030204 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.4 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 1.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.4 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 0.5 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.2 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.4 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.2 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.1 | 0.4 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.3 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 2.2 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.2 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 1.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.2 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 2.1 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.1 | 0.1 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.1 | 0.1 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.1 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.2 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.1 | GO:0061054 | dermatome development(GO:0061054) |
0.1 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.2 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 0.2 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.1 | 0.1 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.1 | 2.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 1.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.4 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.5 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.1 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.1 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.1 | GO:0048342 | paraxial mesodermal cell differentiation(GO:0048342) paraxial mesodermal cell fate commitment(GO:0048343) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.1 | GO:0032647 | interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.2 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) |
0.1 | 0.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.7 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 1.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.1 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.2 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.1 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 0.4 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.2 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.1 | 0.3 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.2 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.1 | 0.3 | GO:0021561 | facial nerve development(GO:0021561) |
0.1 | 0.2 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.1 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.0 | GO:0021766 | hippocampus development(GO:0021766) |
0.0 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.0 | 0.2 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.1 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.1 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.0 | GO:0014010 | glial cell proliferation(GO:0014009) Schwann cell proliferation(GO:0014010) |
0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.2 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.0 | 0.0 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.3 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.0 | GO:0002715 | regulation of natural killer cell mediated immunity(GO:0002715) regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.0 | 2.5 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.0 | 0.6 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.3 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.0 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.0 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.2 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.0 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.0 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.2 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.0 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.0 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.0 | 0.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.0 | GO:0021754 | facial nucleus development(GO:0021754) |
0.0 | 0.0 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.0 | 0.2 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.0 | 0.5 | GO:0098781 | rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
0.0 | 0.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.1 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.0 | 0.0 | GO:0045979 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.0 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.0 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.0 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.0 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.0 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.2 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.3 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.0 | 0.2 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 1.3 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.0 | 0.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.1 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.5 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.0 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.1 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.0 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.0 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.2 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.0 | GO:0002768 | immune response-regulating cell surface receptor signaling pathway(GO:0002768) |
0.0 | 0.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.0 | GO:0031223 | auditory behavior(GO:0031223) |
0.0 | 0.1 | GO:0051875 | pigment granule localization(GO:0051875) |
0.0 | 0.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0050935 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.0 | 0.0 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.1 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.5 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.0 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.0 | 0.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.0 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.0 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.0 | GO:0042435 | serotonin metabolic process(GO:0042428) indole-containing compound biosynthetic process(GO:0042435) primary amino compound metabolic process(GO:1901160) |
0.0 | 0.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.1 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.0 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.1 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.5 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:1904478 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.0 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.3 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:0039703 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.0 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.0 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.0 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 0.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 2.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 2.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.6 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.8 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.5 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.5 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.3 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.9 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 0.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 1.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 2.4 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.2 | GO:0030313 | cell envelope(GO:0030313) |
0.1 | 0.6 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.2 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 6.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0044462 | external encapsulating structure(GO:0030312) external encapsulating structure part(GO:0044462) |
0.0 | 0.4 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.2 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0070938 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 1.6 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.4 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.4 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 1.3 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 1.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 1.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.4 | 2.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 1.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 1.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 1.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 1.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 1.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 5.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 2.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 0.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 1.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.9 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 1.9 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 0.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.8 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 0.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 1.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 0.9 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.2 | 0.8 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 1.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.6 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 1.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 2.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 6.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 1.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 4.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.3 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.4 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 1.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 2.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 2.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.1 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.1 | 0.9 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 1.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 2.2 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.1 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 1.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 2.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.3 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.3 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.5 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 3.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 1.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.3 | GO:0000977 | transcription regulatory region sequence-specific DNA binding(GO:0000976) RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 1.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.2 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.2 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.5 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.8 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 4.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.1 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.2 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 1.3 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.1 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.2 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.0 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.0 | 0.5 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.2 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.9 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.3 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 2.0 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.6 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.0 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.1 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.2 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.0 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.5 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.0 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.0 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 4.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 1.5 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.5 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.0 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 3.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 8.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 4.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 3.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 9.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 10.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 5.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 1.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 1.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 4.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 2.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 2.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 1.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 1.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 5.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 4.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 3.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 4.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 3.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 4.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 2.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 3.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 3.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 1.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 3.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 4.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 4.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 1.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 2.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.4 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.0 | 0.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 2.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 1.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.2 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.8 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |